These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32348716)

  • 1. The Impact of Nimodipine Administration through Feeding Tube on Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage.
    Isse FA; Abdallah YEH; Mahmoud SH
    J Pharm Pharm Sci; 2020; 23(1):100-108. PubMed ID: 32348716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of nimodipine formulations and administration techniques via enteral feeding tubes in patients with aneurysmal subarachnoid hemorrhage: A multicenter retrospective cohort study.
    Mahmoud SH; Hefny FR; Panos NG; Delucilla L; Ngan Z; Perreault MM; Hamilton LA; Rowe AS; Buschur PL; Owusu-Guha J; Almohaish S; Sandler M; Armahizer MJ; Barra ME; Cook AM; Barthol CA; Hintze TD; Cantin A; Traeger J; Blunck JR; Shewmaker J; Burgess SV; Kaupp K; Brown CS; Clark SL; Wieruszewski ED; Tesoro EP; Ammar AA; Ammar MA; Binning MJ; Naydin S; Fox N; Peters DM; Mahmoud LN; Keegan SP; Brophy GM
    Pharmacotherapy; 2023 Apr; 43(4):279-290. PubMed ID: 36880540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Nimodipine Interruption due to High Catecholamine Doses Lead to a Greater Incidence of Delayed Cerebral Ischemia in the Setting of Aneurysmal Subarachnoid Hemorrhage?
    Hernández-Durán S; Mielke D; Rohde V; Malinova V
    World Neurosurg; 2019 Dec; 132():e834-e840. PubMed ID: 31404696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Early Versus Late Intravenous Followed by Oral Nimodipine Treatment on the Occurrence of Delayed Cerebral Ischemia Among Patients With Aneurysm Subarachnoid Hemorrhage.
    Samseethong T; Suansanae T; Veerasarn K; Liengudom A; Suthisisang C
    Ann Pharmacother; 2018 Nov; 52(11):1061-1069. PubMed ID: 29783859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks of nimodipine dose reduction during the high-risk period for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Ditz C; Matone MV; Schwachenwald B; Küchler J
    Neurosurg Rev; 2024 Jan; 47(1):37. PubMed ID: 38191859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term, Continuous Intra-Arterial Nimodipine Treatment of Severe Vasospasm After Aneurysmal Subarachnoid Hemorrhage.
    Hockel K; Diedler J; Steiner J; Birkenhauer U; Danz S; Ernemann U; Schuhmann MU
    World Neurosurg; 2016 Apr; 88():104-112. PubMed ID: 26732964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Angiographic Treatment Response to Intra-Arterial Nimodipine Bolus Injection in Patients with Medically Refractory Cerebral Vasospasm After Spontaneous Subarachnoid Hemorrhage.
    Schacht H; Küchler J; Neumann A; Schramm P; Tronnier VM; Ditz C
    World Neurosurg; 2022 Jun; 162():e457-e467. PubMed ID: 35292409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia.
    Luzzi S; Bektaşoğlu PK; Doğruel Y; Güngor A
    Neurosurg Rev; 2024 Jul; 47(1):305. PubMed ID: 38967704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.
    Bele S; Proescholdt MA; Hochreiter A; Schuierer G; Scheitzach J; Wendl C; Kieninger M; Schneiker A; Bründl E; Schödel P; Schebesch KM; Brawanski A
    Acta Neurochir (Wien); 2015 Dec; 157(12):2041-50. PubMed ID: 26439105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Arterial Hypotension in Patients Receiving Peroral or Continuous Intra-arterial Nimodipine After Aneurysmal or Perimesencephalic Subarachnoid Hemorrhage.
    Kieninger M; Gruber M; Knott I; Dettmer K; Oefner PJ; Bele S; Wendl C; Tuemmler S; Graf B; Eissnert C
    Neurocrit Care; 2019 Aug; 31(1):32-39. PubMed ID: 30725331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nimodipine Dose Reductions in the Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage.
    Sandow N; Diesing D; Sarrafzadeh A; Vajkoczy P; Wolf S
    Neurocrit Care; 2016 Aug; 25(1):29-39. PubMed ID: 26690937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-arterial nimodipine infusion for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Cho WS; Kang HS; Kim JE; Kwon OK; Oh CW; Son YJ; Know BJ; Jung C; Hang MH
    Interv Neuroradiol; 2011 Jun; 17(2):169-78. PubMed ID: 21696654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of invasive cerebral vasospasm treatment in patients with spontaneous subarachnoid hemorrhage and delayed cerebral ischemia-continuous selective intracarotid nimodipine therapy in awake patients without sedation.
    Paľa A; Schneider M; Brand C; Pedro MT; Özpeynirci Y; Schmitz B; Wirtz CR; Kapapa T; König R; Braun M
    Neurosurg Rev; 2019 Jun; 42(2):463-469. PubMed ID: 29804157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter to editor: Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia.
    Rizvi SVZ; Zaidi SMF
    Neurosurg Rev; 2024 Aug; 47(1):383. PubMed ID: 39085665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NEWTON-2 Cisternal (Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage): A Phase 2, Multicenter, Randomized, Open-Label Safety Study of Intracisternal EG-1962 in Aneurysmal Subarachnoid Hemorrhage.
    Macdonald RL; Hänggi D; Ko NU; Darsaut TE; Carlson AP; Wong GK; Etminan N; Mayer SA; Aldrich EF; Diringer MN; Ng D; Strange P; Bleck T; Grubb R; Suarez JI
    Neurosurgery; 2020 Dec; 88(1):E13-E26. PubMed ID: 32985652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Survey on Monitoring and Management of Cerebral Vasospasm and Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: The Mantra Study.
    Picetti E; Bouzat P; Bader MK; Citerio G; Helbok R; Horn J; Macdonald RL; McCredie V; Meyfroidt G; Righy C; Robba C; Sharma D; Smith WS; Suarez JI; Udy A; Wolf S; Taccone FS
    J Neurosurg Anesthesiol; 2024 Jul; 36(3):258-265. PubMed ID: 37254166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage with Asymptomatic Angiographic Vasospasm on Admission.
    Aldakkan A; Mansouri A; Jaja BN; Alotaibi NM; Macdonald RL;
    World Neurosurg; 2017 Jan; 97():199-204. PubMed ID: 27717776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigational drugs for vasospasm after subarachnoid hemorrhage.
    Tallarico RT; Pizzi MA; Freeman WD
    Expert Opin Investig Drugs; 2018 Apr; 27(4):313-324. PubMed ID: 29600883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.